Blood factors as biomarkers in osteoporosis: points from the COVID-19 era.
Trends Endocrinol Metab
; 32(9): 672-679, 2021 09.
Article
in English
| MEDLINE | ID: covidwho-1301018
ABSTRACT
The restrictions adopted during the coronavirus disease 2019 (COVID-19) pandemic limiting direct medical consultations and access to healthcare centers reduced the participation of patients with chronic diseases, such as osteoporosis (OP), in screening and monitoring programs. This highlighted the need for new screening diagnostic tools that are clinically effective, but require minimal technical and time commitments, to stratify populations and identify who is more at risk for OP and related complications. This paper provides an overview of the potential use of blood-related factors, such as platelet (PLT)- and monocyte-related factors, as biomarkers able to quickly screen, detect, and monitor OP in both sexes. Such biomarkers might be of key importance not only during the COVID-19 pandemic but also, even more importantly, during periods of better global health stability.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Osteoporosis
/
Blood Platelets
/
Monocytes
/
Biomarkers
/
COVID-19
Type of study:
Diagnostic study
/
Prognostic study
Limits:
Humans
Language:
English
Journal:
Trends Endocrinol Metab
Journal subject:
Endocrinology
/
Metabolism
Year:
2021
Document Type:
Article
Affiliation country:
J.tem.2021.05.005
Similar
MEDLINE
...
LILACS
LIS